Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants?

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Gosling, Roly D ^a   Ghani, Azra C ^b   Deen, Jaqueline L ^c   Von Seidlein, Lorenz ^a   Greenwood, Brian M ^a   Chandramohan, Daniel ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; FANSIDAR; PROTECTIVE AGENT; SULFADOXINE-PYRIMETHAMINE;

ARTICLE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; HUMAN; IMMUNITY; INCIDENCE; INFANT; MALARIA; MATHEMATICAL MODEL; SENSITIVITY ANALYSIS; COMPARATIVE STUDY; DRUG COMBINATION; RANDOMIZED CONTROLLED TRIAL; THEORETICAL MODEL; TREATMENT OUTCOME;

ANTIMALARIALS; DRUG COMBINATIONS; HUMANS; INFANT; MALARIA; MODELS, THEORETICAL; PROTECTIVE AGENTS; PYRIMETHAMINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFADOXINE; TREATMENT OUTCOME;

EID: 42449123147     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-54     Document Type: Article

References (30)

1. Intermittent preventive antimalarial treatment in infants. B Greenwood, Clin Infect Dis 2007 45 26 28 10.1086/518574 17554696
2. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. D Schellenberg C Menendez E Kahigwa J Aponte J Vidal M Tanner H Mshinda P Alonso, Lancet 2001 357 1471 1477 10.1016/S0140-6736(00)04643-2 11377597
3. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. D Schellenberg C Menendez JJ Aponte E Kahigwa M Tanner H Mshinda P Alonso, Lancet 2005 365 1481 1483 10.1016/S0140-6736(05)66418-5 15850632
4. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. D Chandramohan S Owusu-Agyei I Carneiro T Awine K Amponsa-Achiano N Mensah S Jaffar R Baiden A Hodgson F Binka B Greenwood, Bmj 2005 331 727 733 16195288 10.1136/bmj.331.7519. 727
5. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. E Macete P Aide JJ Aponte S Sanz I Mandomando M Espasa B Sigauque C Dobano S Mabunda M DgeDge P Alonso C Menendez, J Infect Dis 2006 194 276 285 10.1086/505431 16826474
6. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. R Kobbe C Kreuzberg S Adjei B Thompson I Langefeld PA Thompson HH Abruquah B Kreuels M Ayim W Busch F Marks K Amoah E Opoku CG Meyer O Adjei J May, Clin Infect Dis 2007 45 16 25 10.1086/518575 17554695
7. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana. FP Mockenhaupt K Reither P Zanger F Roepcke I Danquah E Saad P Ziniel SY Dzisi M Frempong P Agana-Nsiire F Amoo-Sakyi R Otchwemah JP Cramer SD Anemana E Dietz U Bienzle, Antimicrob Agents Chemother 2007 51 3273 3281 17638703 10.1128/AAC.00513-07
8. Intermittent preventive treatment against malaria in infants in Gabon-a randomized, double-blind, placebo-controlled trial. MP Grobusch B Lell NG Schwarz J Gabor J Dornemann M Potschke S Oyakhirome GC Kiessling M Necek MU Langin PK Klouwenberg A Klopfer B Naumann H Altun ST Agnandji J Goesch M Decker CL Salazar C Supan DU Kombila L Borchert KB Koster P Pongratz AA Adegnika I Glasenapp S Issifou PG Kremsner, J Infect Dis 2007 196 1595 1602 10.1086/522160 18008242
9. Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications. C Menendez D Schellenberg E Macete P Aide E Kahigwa S Sanz JJ Aponte J Sacarlal H Mshinda M Tanner PL Alonso, Malar J 2007 6 132 17897454 10.1186/1475-2875-6-132
10. The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. D Schellenberg E Kahigwa C Drakeley A Malende J Wigayi C Msokame JJ Aponte M Tanner H Mshinda C Menendez PL Alonso, Am J Trop Med Hyg 2002 67 17 23 12363058
11. A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. AR Oduro T Anyorigiya A Hodgson P Ansah F Anto NA Ansah F Atuguba G Mumuni J Amankwa, Trop Med Int Health 2005 10 279 284 10.1111/j.1365-3156.2004.01382.x 15730512
12. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. F Abacassamo S Enosse JJ Aponte FX Gomez-Olive L Quinto S Mabunda A Barreto P Magnussen AM Ronn R Thompson PL Alonso, Trop Med Int Health 2004 9 200 208 10.1046/j.1365-3156.2003.01182.x 15040556
13. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. A Alloueche W Bailey S Barton J Bwika P Chimpeni CO Falade FA Fehintola J Horton S Jaffar T Kanyok PG Kremsner JG Kublin T Lang MA Missinou C Mkandala AM Oduola Z Premji L Robertson A Sowunmi SA Ward PA Winstanley, Lancet 2004 363 1843 1848 10.1016/S0140-6736(04)16350-2 15183620
14. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. FP Mockenhaupt S Ehrhardt SY Dzisi J Teun Bousema N Wassilew J Schreiber SD Anemana JP Cramer RN Otchwemah RW Sauerwein TA Eggelte U Bienzle, Trop Med Int Health 2005 10 512 520 10.1111/j.1365-3156.2005.01427.x 15941413
15. Do maternally acquired antibodies protect infants from malaria infection? EM Riley GE Wagner BD Akanmori KA Koram, Parasite Immunol 2001 23 51 59 10.1046/j.1365-3024.2001.00364.x 11240896
16. Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children. D Njama-Meya MR Kamya G Dorsey, Trop Med Int Health 2004 9 862 868 10.1111/j.1365-3156.2004.01277.x 15303990
17. Insecticide-treated bed nets and curtains for preventing malaria. C Lengeler, Cochrane Database Syst Rev 2004 CD000363 15106149
18. Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? D Chandramohan J Webster L Smith T Awine S Owusu-Agyei I Carneiro, Trop Med Int Health 2007 12 743 750 17550471
19. Immunity to non-cerebral severe malaria is acquired after one or two infections. S Gupta RW Snow CA Donnelly K Marsh C Newbold, Nat Med 1999 5 340 343 10.1038/6560 10086393
20. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. JJ Massaga AY Kitua MM Lemnge JA Akida LN Malle AM Ronn TG Theander IC Bygbjerg, Lancet 2003 361 1853 1860 10.1016/S0140-6736(03)13504-0 12788572
21. How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? CJ Sutherland CJ Drakeley D Schellenberg, Malar J 2007 6 161 18053225 10.1186/1475-2875-6-161
22. The changing epidemiology of malaria in Ifakara Town, southern Tanzania. D Schellenberg C Menendez J Aponte C Guinovart H Mshinda M Tanner P Alonso, Trop Med Int Health 2004 9 68 76 10.1046/j.1365-3156.2003.01161.x 14728609
23. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. B Cisse C Sokhna D Boulanger J Milet H Ba el K Richardson R Hallett C Sutherland K Simondon F Simondon N Alexander O Gaye G Targett J Lines B Greenwood JF Trape, Lancet 2006 367 659 667 10.1016/S0140-6736(06)68264-0 16503464
24. Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. GW Fegan AM Noor WS Akhwale S Cousens RW Snow, Lancet 2007 370 1035 1039 17889242 10.1016/S0140-6736(07)61477-9
25. The decline in paediatric malaria admissions on the coast of Kenya. E Okiro SI Hay PW Gikandi SK Sharif A Noor N Peshu K Marsh RW Snow, Malaria Journal 2007 6 doi:10.1186/1475-2875-1186-1151 18005422
26. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. BM Greenwood PH David LN Otoo-Forbes SJ Allen PL Alonso JR Armstrong Schellenberg P Byass M Hurwitz A Menon RW Snow, Trans R Soc Trop Med Hyg 1995 89 629 633 10.1016/0035-9203(95)90419-0 8594677
27. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. C Menendez E Kahigwa R Hirt P Vounatsou JJ Aponte F Font CJ Acosta DM Schellenberg CM Galindo J Kimario H Urassa B Brabin TA Smith AY Kitua M Tanner PL Alonso, Lancet 1997 350 844 850 10.1016/S0140-6736(97)04229-3 9310602
28. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. JJ Aponte C Menendez D Schellenberg E Kahigwa H Mshinda P Vountasou M Tanner PL Alonso, PLoS Med 2007 4 e242 17676985 10.1371/journal.pmed.0040242
29. Intermittent preventive therapy for malaria: progress and future directions. MP Grobusch A Egan RD Gosling RD Newman, Curr Opin Infect Dis 2007 20 613 620 17975412
30. The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. CA Guerra PW Gikandi AJ Tatem AM Noor DL Smith SI Hay RW Snow, PLoS Med 2008 5 e38 18303939 10.1371/journal.pmed.0050038